PURPOSE: We used a population based cancer registry to examine trends in renal cell carcinoma incidence and survival among 4 racial/ethnic groups (white, black, Hispanic and Asian/Pacific Islander) and both genders. MATERIALS AND METHODS: Race/ethnicity, gender, age, staging, length of survival and cause of death data were analyzed using 39,434 cases of renal cell carcinoma from 1988 to 2004 from the California Cancer Registry. Annual age adjusted incidence rates and relative survival rates were calculated for the racial/ethnic and gender groups. These rates and the percent of localized cancer were plotted by year, and Microsoft Excel was used to calculate linear regression equations. Median age was also calculated. Z-tests and chi-square tests were performed to determine p values. RESULTS: An increase in renal cell carcinoma incidence was found with localized cancer accounting for most of the increase. Black patients had a significantly higher incidence rate (p <0.0001) and lower survival rate (p <0.0001) than all other races/ethnicities despite having more localized cancer (p <0.005). Black patients were also diagnosed at a younger age (p <0.0001) than their counterparts. On the other hand Asian/Pacific Islanders had a lower incidence rate (p <0.0001) and higher survival rate (p <0.05) than all other races/ethnicities. Males had approximately twice the incidence rate of females and a lower survival rate (p <0.005). CONCLUSIONS: Higher incidence rates and lower survival rates were identified among black and male patients compared to their counterparts, while Asian/Pacific Islanders showed the opposite trends. Such racial/ethnic and gender disparities in renal cell carcinoma incidence and survival may help elucidate biological, behavioral and environmental factors that can potentially be addressed.
PURPOSE: We used a population based cancer registry to examine trends in renal cell carcinoma incidence and survival among 4 racial/ethnic groups (white, black, Hispanic and Asian/Pacific Islander) and both genders. MATERIALS AND METHODS: Race/ethnicity, gender, age, staging, length of survival and cause of death data were analyzed using 39,434 cases of renal cell carcinoma from 1988 to 2004 from the California Cancer Registry. Annual age adjusted incidence rates and relative survival rates were calculated for the racial/ethnic and gender groups. These rates and the percent of localized cancer were plotted by year, and Microsoft Excel was used to calculate linear regression equations. Median age was also calculated. Z-tests and chi-square tests were performed to determine p values. RESULTS: An increase in renal cell carcinoma incidence was found with localized cancer accounting for most of the increase. Black patients had a significantly higher incidence rate (p <0.0001) and lower survival rate (p <0.0001) than all other races/ethnicities despite having more localized cancer (p <0.005). Black patients were also diagnosed at a younger age (p <0.0001) than their counterparts. On the other hand Asian/Pacific Islanders had a lower incidence rate (p <0.0001) and higher survival rate (p <0.05) than all other races/ethnicities. Males had approximately twice the incidence rate of females and a lower survival rate (p <0.005). CONCLUSIONS: Higher incidence rates and lower survival rates were identified among black and male patients compared to their counterparts, while Asian/Pacific Islanders showed the opposite trends. Such racial/ethnic and gender disparities in renal cell carcinoma incidence and survival may help elucidate biological, behavioral and environmental factors that can potentially be addressed.
Authors: G R Mufti; J R Gove; D F Badenoch; C G Fowler; R C Tiptaft; H R England; A M Paris; M Singh; M H Hall; J P Blandy Journal: Br J Urol Date: 1989-02
Authors: Y Homma; K Kawabe; T Kitamura; Y Nishimura; M Shinohara; Y Kondo; I Saito; S Minowada; Y Asakage Journal: Int J Urol Date: 1995-05 Impact factor: 3.369
Authors: Catherine M Sanders; Sidney L Saltzstein; Matthew M Schultzel; Duy H Nguyen; Helen Shi Stafford; Georgia Robins Sadler Journal: J Cancer Educ Date: 2012-12 Impact factor: 2.037
Authors: Brian R Winters; John L Gore; Sarah K Holt; Jonathan D Harper; Daniel W Lin; Jonathan L Wright Journal: Urol Oncol Date: 2015-08-28 Impact factor: 3.498
Authors: Christopher S Hollenbeak; Lucas E Nikkel; Eric W Schaefer; Evo Alemao; Nasrollah Ghahramani; Jay D Raman Journal: J Manag Care Pharm Date: 2011-10
Authors: Che-kai Tsao; Alexander C Small; Max Kates; Erin L Moshier; Juan P Wisnivesky; Benjamin A Gartrell; Guru Sonpavde; James H Godbold; Michael A Palese; Simon J Hall; William K Oh; Matthew D Galsky Journal: World J Urol Date: 2012-12-08 Impact factor: 4.226
Authors: Julia Mendoza-Pérez; Jian Gu; Luis A Herrera; Nizar M Tannir; Surena F Matin; Jose A Karam; Maosheng Huang; David W Chang; Christopher G Wood; Xifeng Wu Journal: Clin Cancer Res Date: 2015-12-11 Impact factor: 12.531